Compound 7P
| Produktname | Compound 7P |
|---|---|
| CAS-Nummer | 1890208-58-8 |
| Synonyms | 7P; Compound 7P; 7-P; 7P compound |
| Molekülformel | C18H19N3O2 |
| Molekulargewicht | 309.36 g/mol |
| Aussehen | Off-white to light yellow crystalline powder |
| Purity (HPLC) | ≥98,01 TP3T |
| Löslichkeit | Soluble in DMSO, DMF; slightly soluble in ethanol, methanol; practically insoluble in water |
| Lagerung | Store at -20°C, protected from light and moisture |
| Verpackung | 10 mg, 50 mg, 100 mg, 500 mg, 1 g (custom packaging available) |
Brauchst du Hilfe? Kontaktieren Sie unser Team

Synonyme: 7P, Compound 7P, 7-P, 7P compound, 1890208-58-8
In the fast-evolving landscape of epigenetic research, Compound 7P has emerged as a molecule of considerable interest among medicinal chemists and drug discovery scientists. As a potent inhibitor of the histone methyltransferase EZH2, it is widely used as a chemical probe to study chromatin remodeling, gene silencing, and their implications in cancer biology. Its popularity stems from its high selectivity and cellular activity, making it a valuable tool for both basic research and early-stage therapeutic development.
Compound 7P is a small-molecule inhibitor of EZH2, a component of the Polycomb repressive complex 2 (PRC2). It is chemically characterized as a substituted indole derivative with a molecular formula of C18H19N3O2 and a molecular weight of 309.36 g/mol. The compound is typically synthesized through multi-step organic reactions and is available as an off-white to light yellow crystalline powder. Its structure-activity relationship has been optimized to achieve nanomolar potency against both wild-type and mutant EZH2.
Our Compound 7P is produced under strict quality control and is standardized to ≥98% purity by HPLC. It is supplied as a crystalline solid, ensuring consistent performance in assay development and screening campaigns. With its excellent selectivity and cell permeability, Compound 7P is a reliable reference standard for epigenetic studies.
Compound 7P is a synthetic small molecule designed to selectively inhibit EZH2, an enzyme that catalyzes the methylation of histone H3 at lysine 27 (H3K27me3). This methylation mark is associated with transcriptional repression and is often dysregulated in various cancers, including lymphoma and breast cancer. By blocking EZH2 activity, Compound 7P induces apoptosis and inhibits proliferation in EZH2-dependent cell lines.
The compound is typically prepared via a convergent synthesis route involving indole functionalization and amide coupling. It is isolated as a single polymorphic form and is stable under recommended storage conditions. Each batch is thoroughly characterized by 1H NMR, LC-MS, and elemental analysis to confirm identity and purity.
| Parameter | Technische Daten |
|---|---|
| Aussehen | Off-white to light yellow crystalline powder |
| Purity (HPLC) | ≥98,01 TP3T |
| Trocknungsverlust | ≤0,5% |
| Verbrennungsrückstand | ≤0,1% |
| Schwermetalle | ≤ 10 ppm |
| Residual Solvents | Meets ICH Q3C guidelines |
| Microbial Limits | Total aerobic count ≤1000 CFU/g; Yeast & Mold ≤100 CFU/g |
Room,5-0203, Unit 5, Beiyuanmen Street,Xi'an,Shaanxi,China